Amoebiasis treatment in South Korea
South Korea
5,880 patients are sent for treatment

Amoebiasis treatment in South Korea

➤ Amoebiasis treatment in South Korea ➤ 2 clinics Addresses $ Prices for treatments and diagnostics ☺ 7 reviews ✎ Make an appointment ✉ 5,880 patients are sent for treatment

According to the who, amoebiasis is found in almost 10% of the total population. The disease is considered the second most common cause of death from parasitic diseases.

Epidemiological hotbed is Mexico. Therefore, during travel to tropical countries special attention is paid to quality food and drink, as well as the rules of personal hygiene.

Amoebiasis, aka amoebic dysentery — disease characterized by colitis with extraintestinal manifestations. The disease is transmitted fecal-orally, and is called by protozoan parasites. The parasite through the intestinal wall into the blood that migrates to the liver, where it triggers amoebic abscess.

Doclandmed.com recommends only those doctors and technology, which are recognized as best in the world.

We found 2 clinics specialized in amoebiasis with cumulative rating
4,5
Best choice!
Medical center Gil, University of Gachon specialised on treatment amoebiasis
Medical center Gil University Gachon is a multidisciplinary center, which provide various medical services to patients from all over the world. Highly skilled hospital staff, applying the latest technology and most modern equipment will be able to ...
Contact clinic
+7 499 348 2738 (free)
English speaking staff
Reliable alternative!
Samsung medical center specialised on treatment amoebiasis
Samsung medical center, awarded the title of "Hospital of the presidential standards", offers its patients a variety of medical services pursuant to more than twenty core areas. For treatment use only modern equipment and innovative technology.
Contact clinic
+7 499 348 2738 (free)
English speaking staff

We found 2 clinics specialized in Venereal diseases in South Korea

Question and answers

No questions asked

Ask a question

By continuing to use this site, you agree to our Terms of Use cookie-files.

Accept